May 20, 2026
HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Clinical Trial of HTX-001
Read More
May 14, 2026
Nyra Medical to Highlight First-in-Human Clinical Insights Through Three Presentations at EuroPCR
Read More
Mar 18, 2026
IsomAb appoints Dr Philip Brainin as Chief Executive Officer
Download PDF
Jan 12, 2026
Abbott and AtaCor Medical Collaborate on Advanced Extravascular ICD Technology
Read More
Jan 8, 2026
FineHeart secures €83 million to support its growth and establish itself as a future European leader in Active Implantable Medical Devices (AIMDs)
Download PDF
Jan 8, 2026
Antag Therapeutics demonstrates compelling potential of its novel GIPR antagonist for obesity, reporting excellent tolerability in Phase 1 and enhanced weight loss in amylin combination study
Read More
12345